Artificial Implants Market By Product Type (Orthopedic Implants, Cardiovascular Implants, Spinal Implants, Dental Implants & Others), By Biomaterial (Metallic, Ceramic, Polymers & Natural), By Geography - Global Opportunity Analysis & Industry Forecast, 2022-2027
Artificial Implants Market Overview
Artificial Implants Market size is estimated to reach $63,531 million by 2027, growing at a CAGR of 7.2% during the forecast period 2022-2027. Artificial implants can be utilized to supplement or substitute any portion or function of the body. These are made of materials that are immune system inert, meaning they will not bring about allergic reactions. They are used to treat not only incessant, long-term ailments, but also emergency cases when the accelerated failure of an organ is hard to control and needs instant replenishment with implants. In dentistry and orthopedics, artificial implants are utilized to mimic bone and joint function. These implants are frequently constructed of hard metals like pure titanium or titanium alloys that are connected to natural bone. The ability of the body to build and maintain normal bone structure surrounding the implant in a process called osseointegration determines the stability of the implant after the initial implantation. Hydroxylapatite (HA) has been used clinically for numerous years. It has good biocompatibility with bone contact owing to its chemical composition is very much alike to that of bone material. Hydroxyapatite (HA or HAP) of biologic (coral-, bovine- or marine algae-derived) or synthetic origin is presently utilized for bone repair and bone regeneration in the form of granules, blocks and scaffolds, by itself or as a composite with polymers or additional ceramics or as coatings on orthopedic or dental implants. A prosthetics implant is an artificial device that substitutes a missing body part, which can be lost by way of trauma, ailment, or a condition existing at birth. Biomedical tissue is a kind of tissue utilized for organ transplantation. An artificial organ is a man-made device that is implanted or combined into a human to substitute a natural organ, for the purpose of bringing back a particular function or a class of connected functions to support the patient in recovering to as normal a life as likely. Artificial implants are artificially manufactured or so-called manmade, in contrast to transplanting organs or tissue. Some of the implants include electronic devices like pacemakers while others are bioactive. A classic Artificial Implants industry application is in the healthcare sector.
The lengthier life spans amidst the population across the world and the heightening application of prosthetic implants are set to drive the Artificial Implants Market. The increasing expenditure on healthcare leading to surging demand for progressive healthcare amidst the general populace and expanding intervention with innovative solutions are set to propel the growth of the Artificial Implants Industry during the forecast period 2022-2027. This represents the Artificial Implants Industry Outlook.
Artificial Implants Market Report Coverage
The “Artificial Implants Market Report - Forecast (2022-2027)" by Industry ARC, covers an in-depth analysis of the following segments in the Artificial Implants Market.
By Product Type - Orthopedic Implants, Cardiovascular
Implants, Spinal Implants, Dental Implants and Others.
By Biomaterial - Metallic, Ceramic, Polymers and Natural.
By Geography - North America (U.S, Canada and Mexico), Europe (Germany, France, UK, Italy, Spain, Russia and Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Australia & New Zealand and Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia, Rest of South America) and Rest Of The World (Middle East, Africa).
- Geographically, North America(Artificial Implants Market share) accounted for the highest revenue share in 2021 and it is poised to dominate the market over the period 2022-2027. The growth is owed to the surging advancement in technology in the healthcare sector resulting in the development of artificial implants, prosthetics implants and artificial organs.
- Artificial Implants Market growth is being driven by the growing occurrences of disabilities and organ failures requiring the application of artificial organs and prosthetics implants and the rising technological advancement in the artificial implants industry. However, wear and migration is issues connected with artificial implants, specifically for total or partial joint replacements and these are some of the factors hampering the growth of the Artificial Implants Market.
- Artificial Implants Market Detailed Analysis on the Strength, Weakness and Opportunities of the prominent players operating in the market will be provided in the Artificial Implants Market report.
Artificial Implants Market Segment Analysis - By Product Type
The Artificial Implants Market based on product type can be further segmented into Orthopedic Implants, Cardiovascular Implants, Spinal Implants, Dental Implants and Others. The Orthopedic Implants Segment held the largest Artificial Implants market share in 2021. This growth is owing to the surging application of orthopedic implants for trauma treatments, knee & hip replacement surgeries and more. The soaring count of elderly adults results in a higher prevalence of osteoarthritis and other conditions leading to injuries requiring orthopedic implants. The geriatric population mostly endures knee issues which increases the need for knee implants. Total hip or knee replacement is effective in improving joint function, quality of life and pain reduction. The population of the oldest old (aged 85 years and older) is the fastest-growing segment of the elderly population in western society. Artificial organs are required for cardiac assist devices, orthopedic devices, neuroprostheses and neurological backing, urological backing, visual backing, blood cell and tissue replacement and autoimmune and metabolic therapy treatments. The health status decreases with increasing chronological age. One of the major age-related diseases is osteoarthritis (OA), which is more common in females. As per World Health Organization (WHO), the count of persons aged 80 years or older is anticipated to triple between 2020 and 2050 to arrive at 426 million which will increase the rate of orthopedic issues among the older generation and this is further propelling the growth of the Orthopedic Implants segment.
Furthermore, the Dental Implants segment is estimated to grow with the fastest CAGR of 8.9% during the forecast period 2022-2027 owing to the proliferating application of dental implants to back dental prosthetics including crown, bridge, denture, facial prosthesis or to serve as an orthodontic anchor and surge in the acceptance of cosmetic dentistry.
Artificial Implants Market Segment Analysis - By Biomaterial
The Artificial Implants Market based on biomaterial can be further segmented into Metallic, Ceramic, Polymers and Natural. The Metallic Segment held the largest Artificial Implants market share in 2021. This growth is owing to the metallic implants being the most typical biomaterials used in joint replacement and growing more popular. Stainless steel, CoCr alloys and Ti and Ti alloys are the three kinds of metallic implants utilized in orthopedic applications. These metallic materials offer different features that make them an ideal alternative for complete joint replacement, including high strength, high fracture toughness, hardness, corrosion resistance and biocompatibility. Greater than 120,000 artificial hip joints are being implanted annually in the U.S. Among all implants, metallic implants are the most typical orthopedic implants owing to their superior mechanical properties and are frequently utilized for joint replacement, spinal fusion, bone trauma repair and more. Hydroxylapatite [HAp, Ca10(PO4)6(OH)2] is the most extensively utilized calcium phosphate bioceramic for coatings of metal prostheses owing to its osteogenic characteristic and ability to form powerful bonds with the host bone tissues which is further propelling the growth of this segment.
Furthermore, the Ceramic segment is estimated to grow with the fastest CAGR of 9.4% during the forecast period 2022-2027 owing to the ceramic materials being used mostly in orthopedic and dental implants. In the dental industry, the use of ceramic material for dental implants is surging owing to this material assisting in a natural look thereby raising the demand for ceramic material among patients. The application of hydroxyapatite ceramic (HAC) implants for the treatment of skull defects in pediatric patients has been observed. Modern ceramic implants include TZP ceramic which significantly reduces the risk of fracture. Dental ceramic implants have no allergic reaction which is further fuelling the growth of this segment.
Artificial Implants Market Segment Analysis - By Geography
The Artificial Implants Market based on geography can be further segmented into North America, Europe, Asia-Pacific, South America and Rest of the World. North America (Artificial Implants Market) held the largest Artificial Implants market share with 37% of the overall market in 2021. Artificial implants are being developed as a result of the rapid growth in technology in the healthcare sector in the North American region. Heart valves, stents and grafts, prosthetic joints, ligaments and tendons, hearing loss implants, dental implants, breast implants and nerve stimulation devices are all examples of artificial implants. As per the U.S. Food and Drug Administration (FDA), there are two kinds of breast implants approved for sale in the U.S.: saline-filled and silicone gel-filled. Both kinds have a silicone outer shell. Artificial implants should possess certain properties like good dimensional tolerance, ability to be modified during surgery to fit the patient, high fracture toughness, good fatigue resistance, comparable strength and modulus to that of bone and high wear resistance. Moreover, owing to the rising geriatric population, the incidence of organ failures among old people increases which in turn escalates the demand for artificial implants and artificial organs in the U.S. and this is further propelling the growth of the Artificial Implants Industry in the North American region.
Furthermore, the Asia-Pacific region is estimated to be the region with the fastest CAGR rate over the forecast period 2022-2027. This growth is owing to factors like the heightening healthcare expenditure in the Asia-Pacific region. Biomedical tissue is biological tissue utilized for organ transplantation and medical research, specifically cancer research. The increasing occurrences of disabilities and technological progress resulting in improved applications are further fuelling the growth of the Artificial Implants Industry in the Asia-Pacific region.
Artificial Implants Market Drivers
Surging Applications of Artificial Implants to Substitute a Missing Biological Structure are Propelling the Growth of the Artificial Implants Market
An implant is a medical device manufactured to substitute a missing biological structure, back an impaired biological structure, or improve an existing biological structure. Medical implants are man-made devices, against a transplant, which is a transplanted biomedical tissue. Implants can be classified into classes by application. Sensory and neurological implants are utilized for ailments influencing the principal senses and the brain, as well as additional neurological ailments. They are predominately utilized in the treatment of conditions like cataracts, glaucoma, keratoconus and other visual deteriorations. Cardiovascular medical devices are implanted in cases where the heart, its valves and the rest of the circulatory system are in disarray. They are utilized to treat conditions like heart failure, cardiac arrhythmia, ventricular tachycardia, valvular heart disease, angina pectoris and atherosclerosis. Examples involve the artificial heart, artificial heart valve, implantable cardioverter-defibrillator, cardiac pacemaker and coronary stent. Orthopaedic implants assist in relieving issues with the bones and joints of the body. They are utilized to treat bone fractures, osteoarthritis, scoliosis, spinal stenosis and chronic pain. Examples involve an extensive assortment of pins, rods, screws and plates utilized to anchor fractured bones while they heal. Classically, ultrahigh-molecular-weight polyethylene (UHMWPE) articulating against a metallic surface (counterpart) was the most typically utilized bearing couple displaying an extensive series of wear rates from 0.01 to numerous millimeters per year. The earliest ocular implant prepared of hydroxylapatite was implanted in 1985, by Dr. Arthur Perry and was prepared from a specific genus of reef-building coral, which was modified from calcium carbonate to calcium phosphate, by hydrothermal exchange reaction, which also eliminated proteins and residua. Dental implant prosthetics are structures that include artificial teeth and they substitute any that have been misplaced. The surging applications of artificial implants are therefore propelling the growth of the Artificial Implants Market during the forecast period 2022-2027.
Soaring Innovations in Artificial Implants are Fuelling the Growth of the Artificial Implants Industry
When biomedical tissue is utilized for research, it is a biological specimen. These kinds of tissues and organs may be mentioned as implant tissue, allograft, xenograft, skin graft tissue, human transplant tissue, or implant bone. Investigations demonstrate that almost 30% of mature grown-ups have some kind of restorative dentistry requirement in their lifetime. The inorganic material in human teeth is principally constituted of a calcium phosphate connected to hydroxylapatite (HAP). Presently, dental implants are the only permanent solution to a missing tooth. With raised awareness regarding the advantages of dental implants, the industry is expanding exponentially. Owing to this reason, there is a surging influx of research grants for the dental implant industry, developing novel implant designs and other innovations that assist in resolving existing problems connected to implants. Possibly, one of the most concerning issues at the time of the early phases of dental implants was the tooth replicas that were not an ideal match for the patient. While this is a purely aesthetic concern, it could make all the distinctness when it comes to developing confidence in a patient. Presently, thanks to the developments in dental design technologies, it is feasible to get an exact match – involving the colour of teeth – for dental implants in NW Calgary. CAD-CAM systems in dentistry assists in developing a complete inlay within around an hour with the application of 3D Imaging. Zero bone loss implants are a new innovation in the dental implant industry. It involves augmenting the soft tissue around the implant with novel material. This procedure is still at the clinical research level, however, it seems to offer greatly promising outcomes for finishing a dental implant procedure with virtually zero bone loss. These kinds of soaring innovations in artificial implants are further fuelling the growth of the Artificial Implants Industry, thereby contributing to the Artificial Implants Industry Outlook.
Artificial Implants Market Challenges
The Rising Risks of Artificial Implants are Hampering the Growth of the Artificial Implants Market
A medical implant is a synthetic device, against a transplant, which is a transplanted biomedical tissue. Presently, there is no standard manufacturing guideline existing for arranging hydroxylapatite (HA) on implant surfaces. The risks of medical implants include surgical risks during placement or removal, infection and implant failure. Some people are allergic to the materials used in implant surgery. All surgical procedures have risks. These include bruising at the surgical site, pain, swelling and redness. Infections are typical. Most come from skin contamination at the time of surgery. As per the American Academy of Implant Dentistry, around 500,000 people per year accept an implant in the U.S. As with any surgery, placing dental implants presents some health risks. Problems are rare and when they do occur, are typically easily treatable. Complications relating to dental implants can include injury or damage to the surrounding teeth, blood vessels, nerves, or jaw. Dental implants can also cause complications like infections, gum recession and nerve and tissue damage. These issues are restraining the growth of the Artificial Implants Market.
Artificial Implants Industry Outlook
Product launches, mergers and acquisitions, joint ventures and geographical expansions are key strategies adopted by players in the Artificial Implants Market. The top 10 companies in the Artificial Implants market are:
- Cochlear Limited
- Exactech Inc.
- Aesculap Implant Systems
- Advanced Bionics Corporation
- DSM Biomedical
- Boston Scientific Corporation
- Dentsply International
- DePuy Spine Inc.
- GS Medical LLC
- In January 2022, TODOC, a technology leader in neural prosthesis and neuromodulation systems in Korea, declared that the firm will launch their artificial cochlear implant 'SULLIVAN' at the "CES 2022" which will be held in Las Vegas on January 5, 2022 (local time), after it was chosen in the 'Top 10 Korean Products of CES 2022.' Organized by the ETNews (Electronic Times Internet), "Top 10 Korean Products of CES 2022" is a project that chooses Korean products and services worth paying attention to at this year's CES. The project regards originality, marketability, possibility of mass production and investment value amidst small and medium-sized enterprises and venture firms in Korea.
- In December 2021, BICO (formerly Cellink) declared cooperation with Nanochon – a startup building up regenerative joint prostheses. Under the terms of the contract, Nanochon will buy USD 1.5 million worth of products and services from SCIENION, a subsidiary of BICO, to establish 3D-printed regenerative joint implants. The innovative technology developed by Nanochon can offer patients with quicker and more efficient recovery while decreasing costs for healthcare providers, insurance firms and patients.
- In January 2021, Ortoma AB introduced an artificial intelligence-based software platform that targets to enhance surgical accuracy. The firm's Ortoma Treatment Solution (OTS) has marketing approval in both Europe and the U.S. OTS 5 has been established for application with surgical instruments and involves a big number of enhancements to existing functionalities and different novel ones. This concludes the Artificial Implants Industry Outlook.
Report Code - HCR 1300
Report Code - HCR 1228
Report Code - HCR 32990
For more Lifesciences and Healthcare Market reports, please click here